Skip to main content
×
Home

The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies

  • S. Lev-Ran (a1) (a2) (a3) (a4), M. Roerecke (a2), B. Le Foll (a3) (a5) (a6) (a7), T. P. George (a7) (a8) (a9), K. McKenzie (a1) (a2) (a7) (a10) and J. Rehm (a2) (a11)...
Abstract
Background

Longitudinal studies reporting the association between cannabis use and developing depression provide mixed results. The objective of this study was to establish the extent to which different patterns of use of cannabis are associated with the development of depression using meta-analysis of longitudinal studies.

Method

Peer-reviewed publications reporting the risk of developing depression in cannabis users were located using searches of EMBASE, Medline, PsychINFO and ISI Web of Science. Only longitudinal studies that controlled for depression at baseline were included. Data on several study characteristics, including measures of cannabis use, measures of depression and control variables, were extracted. Odds ratios (ORs) were extracted by age and length of follow-up.

Results

After screening for 4764 articles, 57 articles were selected for full-text review, of which 14 were included in the quantitative analysis (total number of subjects = 76058). The OR for cannabis users developing depression compared with controls was 1.17 [95% confidence interval (CI) 1.05–1.30]. The OR for heavy cannabis users developing depression was 1.62 (95% CI 1.21–2.16), compared with non-users or light users. Meta-regression revealed no significant differences in effect based on age of subjects and marginal difference in effect based on length of follow-up in the individual studies. There was large heterogeneity in the number and type of control variables in the different studies.

Conclusions

Cannabis use, and particularly heavy cannabis use, may be associated with an increased risk for developing depressive disorders. There is need for further longitudinal exploration of the association between cannabis use and developing depression, particularly taking into account cumulative exposure to cannabis and potentially significant confounding factors.

Copyright
Corresponding author
* Address for correspondence: S. Lev-Ran, Addiction Medicine Services, Department of Psychiatry, Sheba Medical Center, Tel Hashomer, Israel. (Email: shauli.levran@gmail.com)
References
Hide All
Anstey KJ, Christensen H, Butterworth P, Easteal S, Mackinnon A, Jacomb T, Maxwell K, Rodgers B, Windsor T, Cherbuin N, Jorm AF (2012). Cohort profile: the PATH through life project. International Journal of Epidemiology 41, 951960.
Beard JR, Dietrich UC, Brooks LO, Brooks RT, Heathcote K, Kelly B (2006). Incidence and outcomes of mental disorders in a regional population: the Northern Rivers Mental Health Study. Australian and New Zealand Journal of Psychiatry 40, 674682.
Block JH, Gjerde PF (1991). Personality antecedents of depressive tendencies in 18-year-olds: a prospective study. Journal of Personality and Social Psychology 60, 726738.
Bovasso GB (2001). Cannabis abuse as a risk factor for depressive symptoms. American Journal of Psychiatry 158, 20332037.
Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M (2002). Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry 59, 10391044.
Brook JS, Cohen P, Brook DW (1998). Longitudinal study of co-occurring psychiatric disorders and substance use. Journal of the American Academy of Child and Adolescent Psychiatry 37, 322330.
Brook JS, Lee JY, Brown EN, Finch SJ, Brook DW (2011). Developmental trajectories of marijuana use from adolescence to adulthood: personality and social role outcomes. Psychological Reports 108, 339357.
Brook JS, Rosen Z, Brook DW (2001). The effect of early marijuana use on later anxiety and depressive symptoms. NYS Psychologist 13, 3540.
Chen CY, Wagner FA, Anthony JC (2002). Marijuana use and the risk of major depressive episode – epidemiological evidence from the United States National Comorbidity Survey. Social Psychiatry and Psychiatric Epidemiology 37, 199206.
Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. Journal of the American Medical Association 291, 21142121.
Degenhardt L, Coffey C, Romaniuk H, Swift W, Carlin JB, Hall WD, Patton GC (2013). The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 108, 124133.
Degenhardt L, Hall W, Lynskey M (2001). Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction 96, 16031614.
Degenhardt L, Hall W, Lynskey M (2003). Exploring the association between cannabis use and depression. Addiction 98, 14931504.
Degenhardt L, Lynskey M, Hall W (2000). Cohort trends in the age of initiation of drug use in Australia. Australian and New Zealand Journal of Public Health 24, 421426.
Derogatis LR (1994). Symptoms Checklist-90-R (SCL-90-R): Administration Scoring and Procedures Manual. National Computer Systems: Minneapolis, MN.
Derogatis LR, Lipman RS, Richels K, Uhlenhuth EH, Covi L (1974). The Hopkins Symptom Checklist: a self-report symptom inventory. Behavioral Science 19, 115.
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177188.
Duval S, Tweedie R (2000). Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455463.
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 315, 629634.
ElSohly MA, Ross SA, Mehmedic Z, Arafat R, Yi B, Banahan BF 3rd (2000). Potency trends of Δ9-THC and other cannabinoids in confiscated marijuana from 1980–1997. Journal of Forensic Sciences 45, 2430.
European Monitoring Centre for Drugs and Drug Addiction (2011). 2011 Annual Report on the State of the Drugs Problem in Europe. EMCDDA: Lisbon.
Fergusson DM, Horwood LJ (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction 92, 279296.
Fergusson DM, Horwood LJ, Swain-Campbell N (2002). Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 97, 11231135.
Fergusson DM, Lynskey MT, Horwood LJ (1996). The short-term consequences of early onset cannabis use. Journal of Abnormal Child Psychology 24, 499512.
Georgiades K, Boyle MH (2007). Adolescent tobacco and cannabis use: young adult outcomes from the Ontario Child Health Study. Journal of Child Psychology and Psychiatry and Allied Disciplines 48, 724731.
Grant BF (1995). Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. Journal of Substance Abuse 7, 481497.
Grant BF, Pickering R (1998). The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse 10, 255264.
Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 61, 807816.
Hall W, Babor TF (2000). Cannabis use and public health: assessing the burden. Addiction 95, 485490.
Hall W, Degenhardt L (2009). Adverse health effects of non-medical cannabis use. Lancet 374, 13831391.
Hall W, Solowij N (1998). Adverse effects of cannabis. Lancet 352, 16111616.
Harder VS, Morral AR, Arkes J (2006). Marijuana use and depression among adults: testing for causal associations. Addiction 101, 14631472.
Harder VS, Stuart EA, Anthony JC (2008). Adolescent cannabis problems and young adult depression: male–female stratified propensity score analyses. American Journal of Epidemiology 168, 592601.
Hill MN, Gorzalka BB (2009). Impairments in endocannabinoid signaling and depressive illness. Journal of the American Medical Association 301, 11651166.
Horder J, Harmer CJ, Cowen PJ, McCabe C (2010). Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers. International Journal of Neuropsychopharmacology 13, 11031113.
Horwood LJ, Fergusson DM, Coffey C, Patton GC, Tait R, Smart D, Letcher P, Silins E, Hutchinson DM (2012). Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug and Alcohol Dependence 126, 369378.
Jané-Llopis E, Matytsina I (2006). Mental health and alcohol, drugs and tobacco: a review of the co-morbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review 25, 515536.
Kandel DB, Davies M (1982). Epidemiology of depressive mood in adolescents: an empirical study. Archives of General Psychiatry 39, 12051212.
Kandel DB, Davies M (1986). Adult sequelae of adolescent depressive symptoms. Archives of General Psychiatry 43, 255262.
Kendler KS, Heath AC, Neale MC, Kessler RC, Eaves LJ (1993). Alcoholism and major depression in women. A twin study of the causes of comorbidity. Archives of General Psychiatry 50, 690698.
Le Foll B, Gorelick DA, Goldberg SR (2009). The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology 205, 171174.
Lipsey MW, Wilson DB (2001). Practical Meta-Analysis. SAGE Publications, Inc.: Thousand Oaks, CA.
Manheimer DI, Mellinger G, Somers R, Kleman MK (1972). Technical and ethical considerations in data collection. In Student Drug Surveys (ed. Einstein S. and Allen S.), pp. 205214. Baywood: Farmingdale, NY.
Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Allebeck P (2012). Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry 12, 112.
Marmorstein NR, Iacono WG (2011). Explaining associations between cannabis use disorders in adolescence and later major depression: a test of the psychosocial failure model. Addictive Behaviors 36, 773776.
McGee R, Williams S, Poulton R, Moffitt T (2000). A longitudinal study of cannabis use and mental health from adolescence to early adulthood. Addiction 95, 491503.
Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, Lewis G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319328.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007). Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851858.
Paton S, Kessler R, Kandel D (1977). Depressive mood and adolescent illicit drug use: a longitudinal analysis. Journal of Genetic Psychology 131, 267289.
Patten SB, Williams JV, Lavorato DH, Bulloch AG, MacQueen G (2012). Depressive episode characteristics and subsequent recurrence risk. Journal of Affective Disorders 140, 277284.
Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W (2002). Cannabis use and mental health in young people: cohort study. British Medical Journal 325, 11951198.
Pedersen W (2008). Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatrica Scandinavica 118, 395403.
Prior M, Sanson A, Smart D, Oberklaid F (2000). Pathways from infancy to adolescence: Australian Temperament Project 1983–2000. Australian Institute of Family Studies: Melbourne, Australia.
Rehm J, Arminger G, Kohlmeier L (1992). Using follow-up data to avoid omitted variable bias: an application to cardiovascular epidemiology. Statistics in Medicine 11, 11951208.
Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, Sempos CT, Frick U, Jernigan D (2004). Alcohol use. In Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors (ed. Ezzati M., Lopez A. D., Rodgers A. and Murray C. J. L.), pp. 9591108. World Health Organization: Geneva.
Robins LN, Helzer JE, Groughan J (1981). National Institute of Mental Health Diagnostic Interview Schedule, version III: PHS Publication ADM-T-42-3. NIMH: Rockville, MD.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Journal of the American Medical Association 283, 20082012.
United Nations Office on Drugs and Crime (2011). World Drug Report. United Nations Office on Drugs and Crime: Vienna.
Ustün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry 184, 386392.
van Laar M, van Dorsselaer S, Monshouwer K, de Graaf R (2007). Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 102, 12511260.
Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK (1996). Cross-national epidemiology of major depression and bipolar disorder. Journal of the American Medical Association 276, 293299.
Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P (2005). Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analysis (http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm). Accessed 10 February 2012.
Windle M, Wiesner M (2004). Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Development and Psychopathology 16, 10071027.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 70
Total number of PDF views: 475 *
Loading metrics...

Abstract views

Total abstract views: 3625 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 22nd November 2017. This data will be updated every 24 hours.